ID: ALA3353291

Max Phase: Preclinical

Molecular Formula: C25H19F3N2O3

Molecular Weight: 452.43

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc([C@]23c4ccccc4C(=O)N2CCN3C(=O)c2cc(F)c(F)c(F)c2)cc1C

Standard InChI:  InChI=1S/C25H19F3N2O3/c1-14-11-16(7-8-21(14)33-2)25-18-6-4-3-5-17(18)24(32)30(25)10-9-29(25)23(31)15-12-19(26)22(28)20(27)13-15/h3-8,11-13H,9-10H2,1-2H3/t25-/m1/s1

Standard InChI Key:  LYXGACOPHGGKEX-RUZDIDTESA-N

Associated Targets(Human)

Plasma 7708 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Muscarinic acetylcholine receptor M5 4677 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Muscarinic acetylcholine receptor M5 132 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 452.43Molecular Weight (Monoisotopic): 452.1348AlogP: 4.23#Rotatable Bonds: 3
Polar Surface Area: 49.85Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 5.02CX LogD: 5.02
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.56Np Likeness Score: -0.57

References

1. Kurata H, Gentry PR, Kokubo M, Cho HP, Bridges TM, Niswender CM, Byers FW, Wood MR, Daniels JS, Conn PJ, Lindsley CW..  (2015)  Further optimization of the M5 NAM MLPCN probe ML375: tactics and challenges.,  25  (3): [PMID:25542588] [10.1016/j.bmcl.2014.11.082]

Source